All News

Both premenopausal and postmenopausal breast cancer rates are rising globally.

Evidence suggests that individuals who have more severe COVID-19 illness requiring hospitalization may still have symptoms that persist even after recovery from infection.

The project aims to demonstrate the value of collaboration between pharmacists and health care payers in the delivery of patient-centered care.

Pharmacy Times spoke with Ron Lanton, Principal at Lanton Law, about Rutledge v. PCMA and its impact on pharmacy and PBMs.

Although the treatment of cancer is facing many challenges, the pandemic is also creating massive amounts of new data with which to educate patients, conduct new research, and make more informed clinical decisions.

New research suggests vitamin D can help prevent colitis in those using immune checkpoint inhibitors.

Working memory development plateaus in the mid-to-late teens and can begin to decline after age 40.

The researchers found that the effect of ACE inhibitors does not appreciably affect the levels of ACE2 enough to support any changes in the clinical use of these medications.

Which vitamin is so dangerous you can actually get too much of it in food form?

Brexucabtagene autoleucel (Tecartus, Kite Pharma) is indicated for adult patients diagnosed with mantle cell lymphoma (MCL) who have not responded to or who have relapsed following other kinds of treatment.

Budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere, AstraZeneca) has been approved by the FDA for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), according to a press release.

The latest update from the CDC incorporates evidence that informs the duration of isolation and precautions recommended to prevent transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to others while limiting unnecessary prolonged isolation and unnecessary use of laboratory testing resources.

Spinal muscular atrophy is the leading genetic cause of death in infants.

Overtreatment of acute cough can help reduce antibiotic use.

Earlier results of the FAST trial, which was launched in 2004, found that reducing the number of radiotherapy fractions to 5 was feasible and safe in the short term.

Patients with cancer diagnosed more than 24 months ago are at an increased risk of severe COVID-19.